Bregs can release negative regulators such as IL-10, IL-35, and TGF-β to inhibit the immune response, suppress the activity of T cells and natural killer cells, and induce Tregs, myeloid-derived suppressor cells (MDSCs), and angiogenesis, facilitating tumor immune escape (93). This evidence concerns the gene TGFB1 and neoplasm.